This website uses cookies in order to improve our services. If you proceed visiting this website you accept the usage of cookies. For more info please read our Data Privacy statement.


NGS Meetings and Conferences - Human and Cancer Genetics

NGS General  Bioinformatics  Diagnostics & Microbiology  Human & Cancer Genetics  | Plant & Fungi  Single Cell

Human & Cancer Genetics Meetings

GeneMed Conference Feb. 2017

February 22 - 24, Baltimore, USA
Genome analysis is rapidly becoming an important tool in biomedical research for study of Future Medicine and health. So focusing on the scope of Genomic Medicine we are organizing this conference to gather top global researchers, leaders and innovators to announce new discoveries, cutting edge breakthroughs.


Frontiers in Cancer Immunotherapy Feb 2017

February 27 - 28, 2017, The New York Academy of Sciences, USA
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.


Rare and Undiagnosed Diseases: Discovery and Models of Precision Therapy March 2017

March 5—8, 2017, Fairmont Copley Plaza, Boston, Massachusetts, USA
Meeting Summary

Of the 7000 known rare diseases, only a fraction have their molecular and mechanistic bases delineated, and many other diseases have yet to be discovered. Characterization of these disorders will reveal new biochemical pathways and cell biological processes, point to potential drug targets, and provide hope for millions of affected individuals. This meeting will address approaches and best practices in pursuing rare and undiagnosed disorders, limitations in data sharing as a barrier to new disease discovery, and examples of successful descriptions of new diseases, mechanisms, and treatments. Specific aims include fostering the development of expertise in rare diseases and the definition of their natural histories; an international network of scientists and physicians collaborating on new disease discovery by sharing phenotypic and sequence data; and new therapeutic approaches based upon rare and new disease mechanisms. Through this meeting, participants should become familiar with rare and undiagnosed disease programs, acquire insights into new disease mechanisms, learn about potential therapeutic targets, and establish collaborations that enhance rare disorder expertise and new disease discovery. The meeting will bring together physicians who are expert in rare disorders with scientists who know metabolic pathways and mechanisms, advancing understanding and therapy. A desired outcome of the meeting includes developing lists of clinical and basic research experts for synergistic collaborations, and creating an international organization to perpetuate the joint investigation of rare and new diseases.


2nd Annual Genetics in Forensics Congress March 2017

14-15 March 2017, London, UK
Over 200 delegates representing internationally renowned research & academic institutions, forensic laboratories, government bodies and sequencing solution providers will be present.

Over 40 case studies and presentations focused on future applications of next generation sequencing in forensics, DNA database construction, advances is tools and technologies for DNA profiling, DNA phenotyping and forensic anthropology case studies will be discussed

Including four interactive streams:

Updates in Utilising NGS in Forensic Science
Interpretation, Database and Casework Hurdles: Overcoming Key Challenges in Forensic Genetics Research
Analysing Forensic Applications of DNA markers
Forensic Anthropology Case Studies


Keystone Symposia - RNA-Based Approaches in Cardiovascular Disease March 2017

March 26—30, 2017,Keystone Resort, Keystone, Colorado, USA
Meeting Summary
Cardiac diseases are the leading cause of death worldwide. RNA-based mechanisms and therapeutic approaches are emerging fields in cardiovascular science. This meeting will present and discuss latest developments using both coding RNA and noncoding RNA (such as microRNAs, long noncoding RNAs and circular RNAs) -based approaches to better understand and develop new therapeutic strategies for cardiac diseases. Attendees will benefit from workshops, specific sessions and industrial perspectives covering everything from basic science to clinical translation employing RNA therapeutics in cardiovascular medicine.


Keystone Symposia - DNA Replication and Recombination April 2017

April 2—6, 2017, Santa Fe Community Convention Center, Santa Fe, New Mexico, USA
Meeting Summary
DNA replication and recombination are common to all cells. Errors in these processes lead to many diseases in humans, including cancer, and many fundamental questions are still unresolved. Due to recent technical advances in microscopy and other techniques, these dynamic processes can now be studied in time and space in both prokaryotes and eukaryotes. Moreover, breakthroughs in the biochemical reconstitution of processes in DNA replication and recombination repair as well as single particle electron microscopy promise to reveal new mechanisms at near-atomic resolution; and new DNA sequencing technologies make it possible to study these key processes in great details. Mechanistic similarities across the three domains of life provide new basic principles while differences identify potential targets for therapeutic intervention. The Keystone Symposia “Replication and Recombination” meeting has historically been one of the premiere meetings in this field and one of the very few that brings together scientists working in replication and recombination across all life forms. Because of the close relationship between DNA replication and recombination and their importance for genome stability, this meeting will be held jointly with the Keystone Symposia meeting on "Genomic Instability." Talks at the “Replication and Recombination” meeting will focus on the mechanism and regulation of these processes, with an emphasis on multiple organisms and multiple approaches. Talks in joint sessions will center on the metabolism of stalled replication forks and the importance of chromatin in replication, recombination and genome stability.


Chromatin and epigenetics: from mechanism to function April 2017

Helmholtz Zentrum München, Munich, Germany, April 5—7, 2017
This exciting three day conference will build a bridge between chromatin mechanisms and epigenetic phenomena - two key pillars of modern biology. This conference will cover the latest advances in the chromatin field, ranging from basic molecular mechanisms of transcriptional regulation to complex epigenetic pathways in development, disease and reprogramming across model systems.

Chromatin dynamics
Epigenomics and single cell approaches
Histone, RNA and DNA modifications
Shaping chromatin with ncRNA
Epigenetic phenomena


Precision Medicine Congress April 2017

25 - 26 April 2017, London, UK
200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies

Over 20 presentations and case studies focusing on the key developments in precision medicine discovery, diagnostics, clinical development and genomics

2 interactive streams:

Precision Medicine and Diagnostics in discovery and development
Precision Medicine and Genomics


Advances in Companion Diagnostics Congress April 2017

25 - 26 April 2017, London, UK
200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies

36 presentations and case studies focusing on the key developments in companion diagnostic development, molecular diagnostics, imaging, digital pathology and CDx for NGS technologies

4 interactive streams:

Companion Diagnostics (CDx) development
Advances in Molecular Diagnostics
Imaging and Diagnostic Development
Companion Diagnostics for Next-Generation Sequencing (NGS) platforms


Genome Editing USA Congress May 2017

1-2 May 2017, Boston, USA
Over 250 delegates representing the leading research & academic institutions and clinical research institutions in the USA, as well as leading pharmaceutical and biotech companies from around the globe.

Over 20 presentations dedicated to genome editing technologies and the applications of genome editing in a range of therapeutic areas, including muscular dystrophy, cardiovascular diseases, genetic disorders and immunotherapies.

Co-located with our 2nd Annual Next Generation Sequencing USA Congress and 2nd Annual Single Cell Analysis USA Congress, delegates will also have access to over 50 further presentations focusing on the therapeutic application of next generation sequencing technologies, transferring NGS into the clinic, single cell ‘omics, singlecell analysis technologies.

Including 2 interactive streams:

• Genome Editing Techniques
• Therapeutic Applications of Genome Editing


Advances in Transgenic Technology Congress May 2017

Genome Editing & Advances in Transgenic Technology USA Congress, 10-11 May 2017, Boston, USA

Genome Editing USA 2017 Congress

Over 20 presentations dedicated to genome editing technologies and the applications of genome editing in a range of therapeutic areas, including muscular dystrophy, cardiovascular diseases, genetic disorders and immunotherapies

Including interactive sessions focusing on:

Genome Editing Techniques
Therapeutic Applications of Genome Editing
Drug Discovery & Development Applications

Co-located Advances in Transgenic Technology USA 2017 Congress

Over 20 presentations dedicated to advances in transgenic technologies including therapeutic applications of transgenic genome editing, in vivo CRISPR genetic screening, mouse 3D imaging strategies, genome and epigenetic editing applications in stem cells and transgenic models of oncology, cardiovascular disease and metabolic disorders

Including interactive sessions focusing on:

Transgenic Genome Editing Techniques
Advances in Animal Biotechnology: Discovery & Development
Generation of Transgenic Models – Models of Disease and Applications
Genetics, Epigenetics, Stem Cell Manipulation
Technology Workshop: Novel Transgenic Technologies


Cancer Genomics Nov. 2017

EMBL Heidelberg, Germany
5 - 8 Nov 2017
Why attend?

This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer mouse models and the translation and clinical impact of scientific results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

European Cancer Genomics research is particularly strong in the Heidelberg area, with three International Cancer Genome Consortium ( projects being currently pursued with significant participation from Heidelberg institutions, including EMBL. As in our 2015 meeting, a large number of renowned speakers will be invited, with a strong representation of overseas speakers. The atmosphere at the conference will make this an exceptional event with cutting edge science, extensive scientific discussions and ample possibilities for meetings between and after sessions to facilitate in-depth discussions and new collaborations.


Pin It